Bengt Hallberg

7.4k total citations · 1 hit paper
113 papers, 5.2k citations indexed

About

Bengt Hallberg is a scholar working on Molecular Biology, Neurology and Oncology. According to data from OpenAlex, Bengt Hallberg has authored 113 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Molecular Biology, 45 papers in Neurology and 30 papers in Oncology. Recurrent topics in Bengt Hallberg's work include Neuroblastoma Research and Treatments (45 papers), Cancer therapeutics and mechanisms (24 papers) and Cancer, Hypoxia, and Metabolism (18 papers). Bengt Hallberg is often cited by papers focused on Neuroblastoma Research and Treatments (45 papers), Cancer therapeutics and mechanisms (24 papers) and Cancer, Hypoxia, and Metabolism (18 papers). Bengt Hallberg collaborates with scholars based in Sweden, United Kingdom and Belgium. Bengt Hallberg's co-authors include Ruth H. Palmer, Julian Downward, Charlotte E. Edling, Caroline Grabbe, Thomas Grundström, Maria L. Henriksson, Anders Thornell, Kristina Ruuth, Sydonia Rayter and Peter J. Parker and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Bengt Hallberg

108 papers receiving 5.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology

2013 458 citations Bengt Hallberg, Ruth H. Palmer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bengt Hallberg Sweden	41	3.1k	1.4k	1.2k	972	784	113	5.2k
Marie Arsenian‐Henriksson Sweden	41	4.3k 1.4×	1.5k 1.1×	837 0.7×	340 0.3×	1.6k 2.0×	101	6.3k
Yuchen Jiao China	36	1.9k 0.6×	2.0k 1.4×	810 0.7×	713 0.7×	1.1k 1.4×	89	5.8k
Valérie Combaret France	34	2.3k 0.8×	1.2k 0.8×	2.3k 1.9×	417 0.4×	1.4k 1.8×	88	4.1k
Alan Buckler United States	36	6.9k 2.2×	1.0k 0.7×	1.0k 0.9×	1.4k 1.4×	727 0.9×	66	10.1k
Annalisa Pession Italy	41	3.1k 1.0×	912 0.6×	258 0.2×	675 0.7×	1.2k 1.5×	144	5.8k
Andrew Dodson United Kingdom	34	1.9k 0.6×	1.1k 0.8×	345 0.3×	536 0.6×	910 1.2×	79	3.5k
Henrik Hager Denmark	35	2.7k 0.9×	780 0.6×	362 0.3×	857 0.9×	1.5k 2.0×	119	4.6k
Dawn E. Quelle United States	30	4.5k 1.4×	3.7k 2.6×	356 0.3×	470 0.5×	725 0.9×	70	6.5k
James F. Amatruda United States	40	4.3k 1.4×	925 0.7×	338 0.3×	651 0.7×	672 0.9×	128	6.5k
Yosef Yarden Israel	27	3.2k 1.0×	1.6k 1.1×	247 0.2×	436 0.4×	765 1.0×	49	4.9k

Countries citing papers authored by Bengt Hallberg

Since Specialization

Citations

This map shows the geographic impact of Bengt Hallberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bengt Hallberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bengt Hallberg more than expected).

Fields of papers citing papers by Bengt Hallberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bengt Hallberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bengt Hallberg. The network helps show where Bengt Hallberg may publish in the future.

Co-authorship network of co-authors of Bengt Hallberg

This figure shows the co-authorship network connecting the top 25 collaborators of Bengt Hallberg. A scholar is included among the top collaborators of Bengt Hallberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bengt Hallberg. Bengt Hallberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Guan, Jikui, et al.. (2024). ALK F1174S mutation impairs ALK kinase activity in EML4-ALK variant 1 and sensitizes EML4-ALK variant 3 to crizotinib. Frontiers in Oncology. 13. 1281510–1281510.

Pettersson, Dan, Amin Al-Awar, Ganesh Umapathy, et al.. (2024). Comparison of 177Lu-octreotate and 177Lu-octreotide for treatment in human neuroblastoma-bearing mice. Heliyon. 10(10). e31409–e31409.

Lai, Wei‐Yun, Ganesh Umapathy, Bengt Bergman, et al.. (2023). ALK fusion NSCLC oncogenes promote survival and inhibit NK cell responses via SERPINB4 expression. Proceedings of the National Academy of Sciences. 120(8). e2216479120–e2216479120. 15 indexed citations

Lai, Wei‐Yun, Anh T. Le, Susanne Fransson, et al.. (2022). Novel human-derived EML4-ALK fusion cell lines identify ribonucleotide reductase RRM2 as a target of activated ALK in NSCLC. Lung Cancer. 171. 103–114. 7 indexed citations

Spetz, Johan, et al.. (2021). Neuroblastoma xenograft models demonstrate the therapeutic potential of 177Lu-octreotate. BMC Cancer. 21(1). 950–950. 6 indexed citations

Mus, Liselot, Irina Lambertz, Candy Kumps, et al.. (2020). The ETS transcription factor ETV5 is a target of activated ALK in neuroblastoma contributing to increased tumour aggressiveness. Scientific Reports. 10(1). 218–218. 19 indexed citations

Umapathy, Ganesh, Ruth H. Palmer, & Bengt Hallberg. (2019). P2.14-18 Upregulation of AURKA Leads to Acquired Resistance in EML4-ALK NSCLC Cell Line. Journal of Thoracic Oncology. 14(10). S836–S836. 1 indexed citations

Witek, Barbara, Abeer El Wakil, Christoffer Nord, et al.. (2015). Targeted Disruption of ALK Reveals a Potential Role in Hypogonadotropic Hypogonadism. PLoS ONE. 10(5). e0123542–e0123542. 30 indexed citations

Mazot, Pierre, Alex Cazes, Florent Dingli, et al.. (2012). Internalization and Down-Regulation of the ALK Receptor in Neuroblastoma Cell Lines upon Monoclonal Antibodies Treatment. PLoS ONE. 7(3). e33581–e33581. 25 indexed citations

10.

Schönherr, Christina, Bengt Hallberg, & Ruth H. Palmer. (2012). Anaplastic Lymphoma Kinase in Human Cancer. Critical Reviews™ in Oncogenesis. 17(2). 123–143. 3 indexed citations

11.

Martinsson, Tommy, Therése Eriksson, Jonas Abrahamsson, et al.. (2010). Appearance of the Novel Activating F1174S ALK Mutation in Neuroblastoma Correlates with Aggressive Tumor Progression and Unresponsiveness to Therapy. Cancer Research. 71(1). 98–105. 59 indexed citations

12.

Berghard, Anna, et al.. (2009). ALK expression within the olfactory bulb. Pediatric Radiology. 25(1). 17–8.

13.

Khoo, Nelson K.S., et al.. (2009). The ALK KO display an idiopathic reduction of total body weight. 65(22). 2840–5.

14.

Edling, Charlotte E. & Bengt Hallberg. (2007). c-Kit—A hematopoietic cell essential receptor tyrosine kinase. The International Journal of Biochemistry & Cell Biology. 39(11). 1995–1998. 211 indexed citations

15.

Yasmin, Lubna, et al.. (2006). Delineation of exoenzyme S residues that mediate the interaction with 14‐3‐3 and its biological activity. FEBS Journal. 273(3). 638–646. 18 indexed citations

16.

Aili, Margareta, Bengt Hallberg, Hans Wolf‐Watz, & Roland Rosqvist. (2002). GAP activity of Yersinia YopE. Methods in enzymology on CD-ROM/Methods in enzymology. 358. 359–370. 18 indexed citations

17.

Nilsson, Jonas A., Christina Vallbo, Dongsheng Guo, et al.. (2001). Cloning, Characterization, and Expression of Human LIG1. Biochemical and Biophysical Research Communications. 284(5). 1155–1161. 117 indexed citations

18.

Rosqvist, Roland, et al.. (2000). The Yersinia Protein Kinase A Is a Host Factor Inducible RhoA/Rac-binding Virulence Factor. Journal of Biological Chemistry. 275(45). 35281–35290. 88 indexed citations

19.

Cabal, Helena, et al.. (1999). Environmental externalities of a future fusion plant. 14(1). 46–8. 1 indexed citations

20.

Eriksson, Mikael & Bengt Hallberg. (1992). Familial occurrence of hematologic malignancies and other diseases in multiple myeloma: a case-control study. Cancer Causes & Control. 3(1). 63–67. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact